Sinay Sarl is an environmental consulting firm based in Caen, France, specializing in marine and coastal environmental services. Established in 2007, the company offers a range of solutions for stakeholders in the maritime sector, including impact assessments, underwater acoustics, fishery science, and geotechnical services. Sinay's expertise supports various applications, such as renewable marine energies, fisheries and aquaculture, marine protected areas, and activities related to oil and military operations, as well as harbor management. The firm's focus on collecting and analyzing maritime data enables clients to make informed decisions regarding environmental impacts and resource management.
Domain Therapeutics SA is a biopharmaceutical company based in Illkirch-Graffenstaden, France, focused on the discovery and early development of therapeutic drugs targeting G Protein-Coupled Receptors (GPCRs), which are key drug targets in various diseases. The company specializes in developing treatments for Central Nervous System (CNS) disorders and cancer. Utilizing its proprietary DTect-All technology, Domain Therapeutics identifies both orthosteric and allosteric ligands, including Silent Allosteric Modulators (SAMs), which are not discoverable through conventional methods. This innovative approach allows the company to address challenging GPCRs, including orphan and peptidic receptors. Founded in 2001, the company was previously known as Faust Pharmaceuticals SA before rebranding in December 2008.
77Foods, incorporated in 2019 and headquartered in Saint-Ouen-sur-Seine, France, is focused on creating innovative food alternatives. The company is developing a 100% vegetable edible fat, aiming to provide various types of plant-based meats, with an initial focus on a bacon substitute. Through its commitment to plant-based products, 77Foods seeks to cater to the growing demand for sustainable and healthier food options.
HARDLOOP SARL sells sports products online. The company sells shoes, gloves, bottles, and more. HARDLOOP SARL was incorporated in 2014 and is based in Paris, France.
Developer of an automotive management platform designed to address the entire lifecycle of a vehicle. The company's platform brings instant ordering, visibility, and real-time control while buying a new or used car, streamlines operations by transferring vehicles quickly between sites, agencies, and partners and offers vehicle testing and after-sales services, enabling customers to have access to a full range of services to meet their needs.
SportEasy is a comprehensive, easy-to-use, web and mobile app to manage amateur sports teams. It helps coaches organize their team's games and practices; communicate easily with their players; capture and analyze statistics. It offers players fun, social features to share their passion with their teammates (vote for player of the game, private forum, photo sharing...). SportEasy is available on the web, and as iPhone and Android apps. It is free, although premium paid plans will be available for teams and clubs starting Q1 2015. Launched in France in 2011, SportEasy is now available in French and English.
Expensya SAS is a company based in Paris, France, that specializes in developing multi-platform expense management software solutions. Founded in 2015, it provides a web application designed to streamline the management of professional expense reports. The Expensya application offers a range of features, including expense management, data export, accountant integration, archiving, email processing, mileage expense management, approval flow, cost accounting, and a statistics module. It is compatible with Android, iPhone, and Windows phone, making it accessible for users across different devices.
PEP-Therapy SAS is a biotechnology company based in Evry, France, founded in 2014. The company specializes in the development of cell penetrating and interfering peptides (CP and IP) aimed at delivering targeted therapies for severe diseases, particularly cancer. One of its key products is DPT-PEP1, a peptide designed to inhibit Caspase-9/PP2A protein interactions, effectively triggering apoptosis in cancer cells while preserving the functionality of healthy cells and other signaling pathways. By focusing on the intracellular delivery of these peptides, PEP-Therapy aims to address critical pathological mechanisms, offering a promising approach to cancer treatment.
MedinCell S.A. is a pharmaceutical company based in Jacou, France, that specializes in developing long-acting injectable drug delivery systems using its proprietary BEPO technology. This innovative approach employs biocompatible materials to create formulations that allow for controlled and sustained release of active pharmaceutical ingredients. The company is advancing several product candidates, including mdc-IRM, a subcutaneous injection for schizophrenia currently in Phase III trials, and mdc-CWM, an intra-articular injection aimed at treating pain and inflammation. Additionally, MedinCell is exploring various formulations in research, such as mdc-WWM for contraception and mdc-ANG for central nervous system disorders. The firm focuses on optimizing the efficiency and accessibility of medical treatments across different therapeutic areas through its ongoing research and development efforts.
Iome Bio is a French company founded on discoveries from Sharpe and Kasper (Harvard) laboratories that explore microbiome-based mechanisms to develop new drugs in immuno-oncology. In particular, the company is working on new targets to overcome resistance to checkpoint inhibitors.
Opencell, founded in 2015, specializes in providing an open-source monetization and billing platform designed to address the complexities of subscription and usage-based billing. Building on a telco billing project initiated in 2007, Opencell aims to bridge the gap between expensive legacy billing systems and overly simplistic software solutions. The platform is tailored for diverse sectors, including telecommunications, cloud services, IoT, and utilities, enabling businesses to efficiently manage their revenue streams. With over 40 successful implementations across various industries and countries, Opencell offers a comprehensive solution that simplifies revenue management, making complex billing processes accessible to a wide range of clients.
CorWave SA is a medical device company based in Clichy, France, specializing in the development and manufacture of heart-assist pumps. Founded in 2011, CorWave focuses on innovative technologies to improve patient outcomes in advanced heart failure. Its flagship product, the CorWave Left Ventricular Assist Device (LVAD), employs a unique undulating disc wave pumping mechanism that mimics the natural pulsatile flow of the heart, significantly reducing trauma to the blood and minimizing complications such as clotting and bleeding. This technology contrasts with traditional continuous flow pumps, which lack significant pulsation. Additionally, the company offers Nemo, a minimally invasive cardiac pump designed for patients who are not candidates for LVADs, providing chronic, partial support. CorWave's devices are characterized by low power consumption and compact design, which may enable total implantability with wireless energy transfer systems.
Clim8 SAS, founded in 2015 and based in Ecully, France, specializes in intelligent thermal technology for outwear. The company develops garments equipped with tiny thermal sensors that monitor and analyze the wearer's body temperature. This technology allows for personalized thermo-regulation, activating and adjusting heat levels based on individual needs. By integrating textile and digital sectors, Clim8 offers a solution that not only tracks user activity but also responds dynamically to environmental conditions and user preferences. The innovative approach aims to enhance comfort and warmth for users in various climates, positioning Clim8 as a leader in smart clothing technology.
Enterome SA is a biotechnology company based in Paris, France, with an additional office in Cambridge, Massachusetts. Founded in 2008, it specializes in disease management solutions that leverage its understanding of the gut microbiome. The company focuses on developing biomarkers, companion diagnostics, and therapeutics aimed at treating various microbiome-related diseases, including inflammatory bowel diseases and metabolic disorders. Enterome's innovative approach involves identifying bioactive molecules differentially expressed by the gut microbiome, which are crucial for regulating human physiology and immune responses. The company has established a strategic collaboration with Takeda Pharmaceutical Company to enhance its research and development efforts. By integrating its expertise in the gut microbiome with therapeutic development, Enterome aims to create targeted solutions for complex health challenges.
Saagie is leading the way in big data analytics by providing DataOps Orchestration that accelerates and operationalizes analytic projects. Their mission is to unify people, process and technology enabling organizations to deliver projects from raw data to production in weeks. Saagie delivers unmatched time-to-value, is “open by design” with isolated containers, strong network engineering as well as transparent security and governance bringing trust, privacy, audit and traceability to analytic projects. Saagie includes best-in-class integration with open source and commercial technologies to support today’s Big Data/AI and analytic use cases enabling global companies to realize value from their data intensive initiatives. Ultimately, Saagie provides a Plug and Play Orchestrator for DataOps that accelerates the distribution of Artificial Intelligence (AI) and Big Data to give companies a competitive advantage across industries.
Your Personal Robot Cameraman for INDOOR and OUTDOOR shooting.
Scipio Bioscience is a biotechnology company based in Paris, France, founded in 2017. The company specializes in manufacturing benchtop kits that serve as a sample preparation solution for single-cell studies. These kits are designed for use in sequencing applications within both clinical and basic research, focusing particularly on transcriptomics. By enabling single-cell barcoding in a test tube format, Scipio Bioscience's products facilitate advanced research in single-cell analysis, supporting laboratories in their scientific endeavors.
MaaT Pharma, SA, operates as a biotechnology company. It develops therapies to treat diseases related to gut microbiota imbalance. It also develops a series of microbiome-based drugs which targets mortality and comorbidities associated with blood cancer treatment. The company was founded in 2014 and is based in Lyon, France.
HARDLOOP SARL sells sports products online. The company sells shoes, gloves, bottles, and more. HARDLOOP SARL was incorporated in 2014 and is based in Paris, France.
HARDLOOP SARL sells sports products online. The company sells shoes, gloves, bottles, and more. HARDLOOP SARL was incorporated in 2014 and is based in Paris, France.
The company TIBOT technologies was born in May 2016: its objective, to develop solutions which facilitate the daily life of poultry farming. In 2015, Lætitia and Benoît called on the services of Cimtech, a design office in mechatronics located near Rennes (35), to assess the feasibility of a robot for poultry farming that could bring more comfort and profitability to their daily work.
FeetMe SAS is a medical technology company based in Paris, France, specializing in the development of innovative insoles designed for real-time foot pressure mapping, particularly for diabetic patients. Founded in 2013, the company's insoles incorporate pressure sensors that create detailed pressure maps, alerting patients and healthcare providers to potential changes in plantar pressure. FeetMe's products include connected insoles and mobile software that assess gait and mobility parameters in real-life settings, utilizing advanced algorithms and wireless technology. These solutions are marketed to pharmaceutical companies for clinical trials, as well as to hospitals and rehabilitation centers for mobility assessments and gait training. Ultimately, FeetMe aims to address the growing global issue of mobility disorders, facilitating better therapeutic evaluations and rehabilitation outcomes for patients.
JobTeaser SARL operates a recruitment platform designed for students and recent graduates, facilitating access to internships, job placements, and entry-level positions. Established in 2008 and based in Paris, France, the platform offers over 5,000 job opportunities and provides multimedia resources such as videos showcasing various companies and career paths. Additionally, JobTeaser offers career guidance, advice on job selection, and opportunities for users to engage directly with recruiters. The platform aims to enhance the job search experience for young professionals by combining practical job listings with valuable support and insights into potential career trajectories.
LNC Therapeutics is developing gut microbiota directed drugs to target obesity and associated cardiometabolic diseases. All projects encompass fundamental research, preclinical studies and clinical trials. Backed by leading venture capital investors, such as Seventure Partners (with the microbiome dedicated vehicle Health for Life Capital) and Family Offices, the company cultivates worldwide collaborations with renowned medical experts to ensure the highest level of standards in the development of innovative drugs. With a total of € 16.5 million raised so far including € 1.5 million grants from French BPI and Aquitaine Region, LNC Therapeutics will pursue its research programs to bring the next generation approach to treat obesity and cardiometabolic diseases.
Domain Therapeutics SA is a biopharmaceutical company based in Illkirch-Graffenstaden, France, focused on the discovery and early development of therapeutic drugs targeting G Protein-Coupled Receptors (GPCRs), which are key drug targets in various diseases. The company specializes in developing treatments for Central Nervous System (CNS) disorders and cancer. Utilizing its proprietary DTect-All technology, Domain Therapeutics identifies both orthosteric and allosteric ligands, including Silent Allosteric Modulators (SAMs), which are not discoverable through conventional methods. This innovative approach allows the company to address challenging GPCRs, including orphan and peptidic receptors. Founded in 2001, the company was previously known as Faust Pharmaceuticals SA before rebranding in December 2008.
LiMM Therapeutics operates as a biopharmaceutical company that harnesses the molecular cross-talk between neuronal and innate lymphoid cells. It develops products designed to preserve health and treat inflammatory, infectious, and metabolic diseases. The company is dedicated to bridging neural sensing and immunology discoveries to unlock therapeutic solutions for the benefit of patients.
Glopal S.A.S is a company that specializes in advanced international marketing solutions for ecommerce retailers. Founded in 2019 and based in Paris, France, Glopal offers a comprehensive range of services aimed at helping e-merchants expand their reach globally. These services include international marketing, translation, international SEO, localization, as well as facilitating international payments and shipping. By providing these integrated solutions, Glopal enables online retailers to automatically generate additional sales in international markets.
Expensya SAS is a company based in Paris, France, that specializes in developing multi-platform expense management software solutions. Founded in 2015, it provides a web application designed to streamline the management of professional expense reports. The Expensya application offers a range of features, including expense management, data export, accountant integration, archiving, email processing, mileage expense management, approval flow, cost accounting, and a statistics module. It is compatible with Android, iPhone, and Windows phone, making it accessible for users across different devices.
Presto Engineering, Inc. is a provider of outsourced development operations for semiconductor and Internet of Things (IoT) device companies. Founded in 2006 and headquartered in San Jose, California, the company specializes in a wide array of services including turnkey IoT components, radio-frequency (RF) and mixed-signal solutions, wafer fabrication, and backend processing. It also offers comprehensive testing and qualification services, encompassing product debugging, reliability analysis, and failure analysis. Additionally, Presto Engineering delivers supply chain solutions and various lab services such as electrostatic discharge testing and compliance testing for high-definition multimedia interfaces. With offices in France, Thailand, and Taiwan, Presto Engineering serves a diverse client base, helping them minimize overhead, reduce risk, and accelerate time-to-market in the semiconductor industry.
Safe and simple booking of holiday rental properties
Launchmetrics is a Brand Performance Cloud that arms fashion, luxury, and beauty executives with the tools and data to create inspiring, shareworthy, and measurable experiences to attract today’s modern consumer. With over a decade of experience, the company develops software that helps companies in the fashion, luxury, and cosmetics sectors, helping them grow their businesses and streamline their processes. It is the most essential and trusted technology in the industry, yielding an unrivaled market penetration to 50% of the top 100 luxury brands worldwide in addition to fashion, beauty, and retailer giants such as Dior, Fendi, TopShop, Shiseido, NET-A-PORTER, Adidas, and more. Founded in NYC, with operating headquarters in Paris, Launchmetrics has employees in eight markets and support in five languages. The company works with over 1,000 brands as well as partners like IMG, the Council of Fashion Designers of America, the British Fashion Council, Camera Nazionale della Moda Italiana, Pitti Immagine, and Google, to accelerate their business and build lasting exposure.
Private Equity Round in 2018
MDoloris Medical Systems SAS specializes in the development and manufacturing of medical devices aimed at monitoring and alleviating patient pain. The company offers the Analgesia Nociception Index (ANI) monitors, which provide direct measurements of the autonomic nervous system's activity, along with ANI sensors and PhysioDoloris monitors. These devices are utilized in various settings, including general anesthesia, post-surgical wards, intensive care units, obstetrics, and neonatal care. The technology is particularly valuable for non-communicating patients, enabling healthcare providers to assess and manage pain effectively. Founded in 2010 and based in Loos, France, MDoloris also provides after-sales services to support its clients.
Izicap SAS, founded in 2013 and based in Nice, France, specializes in payment processing solutions for merchants and electronic banking partners. The company offers an innovative digital marketing platform that transforms payment cards into loyalty cards, enabling small merchants and acquirers to effectively engage customers. By capturing and analyzing payment card data, Izicap provides valuable insights through its dashboard and facilitates targeted digital marketing campaigns. Its services include automated loyalty programs and promotional campaigns via email and messaging, catering to a diverse clientele that includes restaurant owners, chain stores, and franchises. Izicap's solutions are designed to enhance customer loyalty and increase spending among end customers.
LiMM Therapeutics operates as a biopharmaceutical company that harnesses the molecular cross-talk between neuronal and innate lymphoid cells. It develops products designed to preserve health and treat inflammatory, infectious, and metabolic diseases. The company is dedicated to bridging neural sensing and immunology discoveries to unlock therapeutic solutions for the benefit of patients.
Indexima is a company based in Montrouge, France, founded in 2016, that specializes in developing a data hub platform aimed at enhancing analytics for data-driven organizations. The platform facilitates immediate access to data for business analysts using popular analytics tools such as Tableau, Microsoft Power BI, Qlik, and others. By leveraging advanced technologies, including artificial intelligence and innovative indexing methods, Indexima enables rapid responses to analytical queries, regardless of the data volume involved. This capability allows companies to streamline their access to commercial, marketing, financial, and technical data, ultimately simplifying and accelerating their data analysis and science processes.
Enterome SA is a biotechnology company based in Paris, France, with an additional office in Cambridge, Massachusetts. Founded in 2008, it specializes in disease management solutions that leverage its understanding of the gut microbiome. The company focuses on developing biomarkers, companion diagnostics, and therapeutics aimed at treating various microbiome-related diseases, including inflammatory bowel diseases and metabolic disorders. Enterome's innovative approach involves identifying bioactive molecules differentially expressed by the gut microbiome, which are crucial for regulating human physiology and immune responses. The company has established a strategic collaboration with Takeda Pharmaceutical Company to enhance its research and development efforts. By integrating its expertise in the gut microbiome with therapeutic development, Enterome aims to create targeted solutions for complex health challenges.
Il Etait Un Fruit SAS is a French company founded in 2014 and located in Lunel, France. Specializing in the production of dried fruit products, the company offers dehydrated fruit petals that are carefully selected for their taste. The fruits are sliced and dried without any additives or added sugars, ensuring that their nutritional value is preserved. Il Etait Un Fruit sources its fruits from the Languedoc Roussillon region, emphasizing quality and natural ingredients in its offerings.
PEP-Therapy SAS is a biotechnology company based in Evry, France, founded in 2014. The company specializes in the development of cell penetrating and interfering peptides (CP and IP) aimed at delivering targeted therapies for severe diseases, particularly cancer. One of its key products is DPT-PEP1, a peptide designed to inhibit Caspase-9/PP2A protein interactions, effectively triggering apoptosis in cancer cells while preserving the functionality of healthy cells and other signaling pathways. By focusing on the intracellular delivery of these peptides, PEP-Therapy aims to address critical pathological mechanisms, offering a promising approach to cancer treatment.
Scipio Bioscience is a biotechnology company based in Paris, France, founded in 2017. The company specializes in manufacturing benchtop kits that serve as a sample preparation solution for single-cell studies. These kits are designed for use in sequencing applications within both clinical and basic research, focusing particularly on transcriptomics. By enabling single-cell barcoding in a test tube format, Scipio Bioscience's products facilitate advanced research in single-cell analysis, supporting laboratories in their scientific endeavors.
FeetMe SAS is a medical technology company based in Paris, France, specializing in the development of innovative insoles designed for real-time foot pressure mapping, particularly for diabetic patients. Founded in 2013, the company's insoles incorporate pressure sensors that create detailed pressure maps, alerting patients and healthcare providers to potential changes in plantar pressure. FeetMe's products include connected insoles and mobile software that assess gait and mobility parameters in real-life settings, utilizing advanced algorithms and wireless technology. These solutions are marketed to pharmaceutical companies for clinical trials, as well as to hospitals and rehabilitation centers for mobility assessments and gait training. Ultimately, FeetMe aims to address the growing global issue of mobility disorders, facilitating better therapeutic evaluations and rehabilitation outcomes for patients.
LNC Therapeutics is developing gut microbiota directed drugs to target obesity and associated cardiometabolic diseases. All projects encompass fundamental research, preclinical studies and clinical trials. Backed by leading venture capital investors, such as Seventure Partners (with the microbiome dedicated vehicle Health for Life Capital) and Family Offices, the company cultivates worldwide collaborations with renowned medical experts to ensure the highest level of standards in the development of innovative drugs. With a total of € 16.5 million raised so far including € 1.5 million grants from French BPI and Aquitaine Region, LNC Therapeutics will pursue its research programs to bring the next generation approach to treat obesity and cardiometabolic diseases.
Eligo Bioscience S.A.S is a biotechnology company based in Paris, France, that specializes in developing Eligobiotics, a novel class of antimicrobials designed to target specific bacteria based on their genetic makeup. Founded in 2014, Eligo Bioscience utilizes a combination of the CRISPR/Cas system and engineered phage capsids to create antibiotics aimed at treating diseases associated with the human microbiome and resistant pathogens. Their innovative approach allows for the precise eradication of virulent bacteria, addressing the growing challenge of antibiotic resistance. The potential applications of their technology extend beyond therapeutics to include areas such as cosmetics and biodefense, positioning Eligo Bioscience at the forefront of next-generation antimicrobial development.
Intento Design SA specializes in developing software solutions that enhance the design and migration processes of analog and mixed-signal integrated circuits. Founded in 2015 and headquartered in Paris, France, the company offers ID-Xplore, a tool that automates circuit sizing and streamlines the analog design process, significantly reducing latency. In addition to its software, Intento Design provides services such as methodology adoption, design collaboration, and technology migration. Their innovative approach aims to address productivity challenges faced by electrical designers, particularly in industries like consumer electronics, the Internet of Things, big data, military, and medical markets. The company's work is rooted in research conducted at the Laboratoire d’Informatique de Paris 6, leading to a robust portfolio of intellectual property that supports its mission to simplify and accelerate the analog design cycle for complex systems on chip (SoCs) used in various connected applications.
Pitchy Bros Prod SAS, founded in 2013 and based in Paris, France, offers a software as a service (SaaS) solution that simplifies the video creation process. Users can select from a variety of ready-to-use templates tailored for different scenarios, such as investor pitches or product descriptions. By uploading their own text, images, logos, and videos, users can produce a personalized video in just a few minutes. Pitchy provides flexible payment options, allowing users to either purchase the video outright or subscribe to a monthly plan, which includes hosting the video on Pitchy's platform. The company utilizes Adobe After Effects to design motion graphics templates, which are accessible through its website, ensuring a streamlined production process without manual intervention.
TargEDys SAS, established in 2011 and located in Rouen, France, focuses on developing innovative mechanisms to address eating disorders such as hyperphagia and anorexia. The company's approach involves hormone mimetic proteins associated with the gut microbiota to regulate appetite. By leveraging naturally occurring bacterial and hormonal mimetic proteins found in the gut, TargEDys aims to help individuals manage their eating behaviors effectively. This technology is designed to assist in controlling metabolic diseases by modulating appetite, thereby benefiting populations such as overweight individuals and those suffering from conditions like cachexia or anorexia.
Business Table is the leader in corporate dining and corporate events, with more than 30,000 service providers, including 15,000 restaurants, 1,500 caterers and 14,000 hotels and locations across France. This innovative solution launched in 2012 allows companies, from large groups to SMEs, to streamline the management of meal costs through a simple, innovative and efficient booking, ordering and invoicing tool. To expand its service offering, Business Table has partnered with American Express, Concur, Edenred and AirPlus
Botfuel SAS is a Paris-based company founded in 2016 that provides a web-based platform for creating chatbots aimed at enhancing customer engagement for businesses. The platform utilizes artificial intelligence to develop modular and scalable chatbots, allowing companies to offer automated and personalized customer support through popular messaging channels. By facilitating interaction between businesses and their customers, Botfuel aims to improve customer service and drive sales, ultimately making customer support more profitable. The solutions provided by Botfuel enable businesses to engage effectively with their audiences while leveraging existing communication platforms.
SAS Chronotruck, founded in 2014 and based in Aubergenville, France, operates an application that connects shippers and carriers in real time. The platform allows users to find trucks for shipments efficiently, aiming to reduce empty journeys for carriers while enhancing profitability for shippers. By offering geo-tagged vehicles for real-time shipment tracking, Chronotruck serves as a marketplace facilitating direct interactions between customers and service providers. As of July 2019, it functions as a subsidiary of GEFCO S.A. and aspires to become the leading logistics platform in Europe for transport orders.
Yelloan SAS, founded in 2015 and based in Paris, France, specializes in providing consumer credit to individuals. The company introduces an innovative approach to credit accessibility through a participatory guarantee system, where a group of at least five relatives or friends of the borrower contributes to a guarantee pot amounting to 5% of the credit requested. This unique model allows lenders to assess the creditworthiness of borrowers based on the trust and support of their personal network, facilitating easier access to loans. By leveraging the financial backing of the borrower's close connections, Yelloan aims to enhance the lending process while fostering a sense of community and responsibility among borrowers.
Aston iTrade Finance is the global online platform dedicated to optimize trade receivables management for customers and suppliers. Their platform is dedicated to corporates, credit insurers and funders.
CryoCapCell is a biotechnology company based in Paris, France, specializing in the development and manufacturing of products for sample preparation in correlative light and electron microscopy (CLEM). Founded in 2011, the company offers a range of innovative solutions, including the CryoCapsule for conducting CLEM studies through vitrification, as well as the HPM Light µ system, which enables live cell imaging paired with vitrification techniques. Additionally, CryoCapCell provides the HPM010 kit for loading CryoCapsules into high-pressure freezers and the HPM100 kit for easy capsule fitting, along with a décapsuleur designed to facilitate freeze substitution and the subsequent processing of samples.
Skinjay SAS offers shower mixers and a collection of aromatic capsules primarily in France, Portugal, and Austria. Its capsules release essential oils aromatic power by merging it with the live warm water of the shower. The company offers its products online. Skinjay SAS was founded in 2012 and is based in Paris, France.
Enterome SA is a biotechnology company based in Paris, France, with an additional office in Cambridge, Massachusetts. Founded in 2008, it specializes in disease management solutions that leverage its understanding of the gut microbiome. The company focuses on developing biomarkers, companion diagnostics, and therapeutics aimed at treating various microbiome-related diseases, including inflammatory bowel diseases and metabolic disorders. Enterome's innovative approach involves identifying bioactive molecules differentially expressed by the gut microbiome, which are crucial for regulating human physiology and immune responses. The company has established a strategic collaboration with Takeda Pharmaceutical Company to enhance its research and development efforts. By integrating its expertise in the gut microbiome with therapeutic development, Enterome aims to create targeted solutions for complex health challenges.
Every healthcare professional has the responsibility to use the latest tech innovations available to fight diseases. Artificial intelligence can sometimes exceed human expertise by unveiling unseen meaning out of huge amounts of data. At Keen Eye, they strive to make that deeper meaning available to every physician, biologist, and patient.
CorWave SA is a medical device company based in Clichy, France, specializing in the development and manufacture of heart-assist pumps. Founded in 2011, CorWave focuses on innovative technologies to improve patient outcomes in advanced heart failure. Its flagship product, the CorWave Left Ventricular Assist Device (LVAD), employs a unique undulating disc wave pumping mechanism that mimics the natural pulsatile flow of the heart, significantly reducing trauma to the blood and minimizing complications such as clotting and bleeding. This technology contrasts with traditional continuous flow pumps, which lack significant pulsation. Additionally, the company offers Nemo, a minimally invasive cardiac pump designed for patients who are not candidates for LVADs, providing chronic, partial support. CorWave's devices are characterized by low power consumption and compact design, which may enable total implantability with wireless energy transfer systems.
Actronika SAS, founded in 2014 and based in Paris, France, specializes in designing and developing hardware and software solutions that provide high-definition tactile experiences for various industries, including medical, gaming, and virtual reality. The company is recognized for its expertise in haptic technology, offering vibrotactile actuators and advanced human-machine interface solutions. Actronika's innovative platforms facilitate seamless system integration, enabling users to engage more meaningfully with digital environments through tangible interactions. By focusing on signal processing within mechatronics and robotics, Actronika aims to enhance user experiences while minimizing maintenance costs, addressing the growing demand for immersive and interactive technologies in an increasingly digital world.
Enterome SA is a biotechnology company based in Paris, France, with an additional office in Cambridge, Massachusetts. Founded in 2008, it specializes in disease management solutions that leverage its understanding of the gut microbiome. The company focuses on developing biomarkers, companion diagnostics, and therapeutics aimed at treating various microbiome-related diseases, including inflammatory bowel diseases and metabolic disorders. Enterome's innovative approach involves identifying bioactive molecules differentially expressed by the gut microbiome, which are crucial for regulating human physiology and immune responses. The company has established a strategic collaboration with Takeda Pharmaceutical Company to enhance its research and development efforts. By integrating its expertise in the gut microbiome with therapeutic development, Enterome aims to create targeted solutions for complex health challenges.
TargEDys SAS, established in 2011 and located in Rouen, France, focuses on developing innovative mechanisms to address eating disorders such as hyperphagia and anorexia. The company's approach involves hormone mimetic proteins associated with the gut microbiota to regulate appetite. By leveraging naturally occurring bacterial and hormonal mimetic proteins found in the gut, TargEDys aims to help individuals manage their eating behaviors effectively. This technology is designed to assist in controlling metabolic diseases by modulating appetite, thereby benefiting populations such as overweight individuals and those suffering from conditions like cachexia or anorexia.
MaaT Pharma, SA, operates as a biotechnology company. It develops therapies to treat diseases related to gut microbiota imbalance. It also develops a series of microbiome-based drugs which targets mortality and comorbidities associated with blood cancer treatment. The company was founded in 2014 and is based in Lyon, France.
MilliDrop Instruments SAS specializes in the design and development of advanced cell culture machines utilizing millifluidics technology, aimed at bacteriological research and diagnostics. Incorporated in 2015 and headquartered in Paris, France, the company offers in vitro diagnostics machines capable of handling samples as small as a few picolitres. Its innovative instruments facilitate the simultaneous study of various cultures, allowing for the analysis, incubation, and manipulation of microbial populations while monitoring phenotypic diversity. MilliDrop also focuses on the development of its next-generation diagnostic instrument, the MilliDrop DIV, which aims to assist users in identifying infectious agents and determining appropriate antibiotic dosages to minimize therapeutic failures. The company’s technology supports microbiologists in conducting high-throughput phenotypic screenings for various microorganisms, including algae, fungi, bacteria, and yeasts, specifically for antimicrobial susceptibility testing.
HorseCom SAS, founded in 2015 and based in Caen, France, specializes in developing Bluetooth audio headset technology specifically designed for horses and their riders. The company aims to improve the well-being, focus, rhythm, and connection between horses and riders through innovative products and services centered around music and technology. HorseCom has created a patented wearable device that plays music tailored for both horse and rider, fostering a stronger bond and enhanced synchronization during training and competitions. This unique device is specially adapted to accommodate equine ears, promoting the horse's well-being, improving performance, and aiding in recovery.
Intento Design SA specializes in developing software solutions that enhance the design and migration processes of analog and mixed-signal integrated circuits. Founded in 2015 and headquartered in Paris, France, the company offers ID-Xplore, a tool that automates circuit sizing and streamlines the analog design process, significantly reducing latency. In addition to its software, Intento Design provides services such as methodology adoption, design collaboration, and technology migration. Their innovative approach aims to address productivity challenges faced by electrical designers, particularly in industries like consumer electronics, the Internet of Things, big data, military, and medical markets. The company's work is rooted in research conducted at the Laboratoire d’Informatique de Paris 6, leading to a robust portfolio of intellectual property that supports its mission to simplify and accelerate the analog design cycle for complex systems on chip (SoCs) used in various connected applications.
MaaT Pharma, SA, operates as a biotechnology company. It develops therapies to treat diseases related to gut microbiota imbalance. It also develops a series of microbiome-based drugs which targets mortality and comorbidities associated with blood cancer treatment. The company was founded in 2014 and is based in Lyon, France.
Mailjet SAS is a cloud-based email platform founded in 2010 and headquartered in Paris, France. It provides a comprehensive solution for managing and tracking both marketing and transactional emails for marketers and developers. Mailjet serves over 26,000 clients across 156 countries, sending nearly 1 billion emails monthly. The platform offers various features, including email personalization, newsletter templates, real-time monitoring, and marketing automation tools. Additionally, it includes robust analytics and reporting capabilities to help users optimize their email campaigns. Mailjet also supports integration with various contact management systems through its APIs, ensuring flexibility and scalability for high-volume senders and agencies. As of October 2019, Mailjet operates as a subsidiary of Mailgun Technologies, Inc.
Eligo Bioscience S.A.S is a biotechnology company based in Paris, France, that specializes in developing Eligobiotics, a novel class of antimicrobials designed to target specific bacteria based on their genetic makeup. Founded in 2014, Eligo Bioscience utilizes a combination of the CRISPR/Cas system and engineered phage capsids to create antibiotics aimed at treating diseases associated with the human microbiome and resistant pathogens. Their innovative approach allows for the precise eradication of virulent bacteria, addressing the growing challenge of antibiotic resistance. The potential applications of their technology extend beyond therapeutics to include areas such as cosmetics and biodefense, positioning Eligo Bioscience at the forefront of next-generation antimicrobial development.
PEP-Therapy SAS is a biotechnology company based in Evry, France, founded in 2014. The company specializes in the development of cell penetrating and interfering peptides (CP and IP) aimed at delivering targeted therapies for severe diseases, particularly cancer. One of its key products is DPT-PEP1, a peptide designed to inhibit Caspase-9/PP2A protein interactions, effectively triggering apoptosis in cancer cells while preserving the functionality of healthy cells and other signaling pathways. By focusing on the intracellular delivery of these peptides, PEP-Therapy aims to address critical pathological mechanisms, offering a promising approach to cancer treatment.
Balyo SA is a company that specializes in the design, development, and marketing of innovative material handling robots. Founded in 2005 and headquartered in Ivry-sur-Seine, France, Balyo transforms standard forklift trucks into autonomous intelligent robots using advanced navigation technology. This allows the robots to operate alongside human workers without the need for additional infrastructure, such as guiding lines or reflectors. Balyo's product range includes robotic stackers, pallet trucks, counterbalanced stackers, tuggers, and various types of trucks, all of which are utilized in diverse logistics applications including storage, loading and unloading, and barcode scanning. The company has established partnerships with prominent players in the material handling industry, enhancing its market presence and facilitating growth in regions such as Europe and the Americas. Balyo's solutions aim to improve efficiency and safety in material handling operations, aligning with modern concepts of automated warehousing and logistics.
Augure, founded in 2002 in Paris, specializes in influencer marketing software that aids brands and agencies in integrating traditional public relations with modern influencer strategies. The platform is utilized by over 1,000 communication, PR, and public affairs teams daily, enabling them to engage relevant influencers, manage campaigns, and enhance their media presence and reputation across social networks. Augure's data services team complements its software offerings by providing consulting support, helping clients interpret data to refine their influencer marketing approaches. The company operates in Europe and Latin America, serving a diverse clientele that includes major organizations such as Orange, Thales, and Château de Versailles.
Created in July 2014, Aenitis Technologies is a French start-up resulting from the work of Mauricio HOYOS and Jean-Luc AIDER, both CNRS researchers at the PMMH Laboratory (Physics and Mechanics of Heterogeneous Media at the ESPCI ParisTech, a research engineer’s school in Paris. The company focuses on medical devices’ area, where their breakthrough technologies are highly promising. Aenitis Technologies is developing innovative separation, manipulation and filtration of biological elements solutions, based on acoustophoresis technologies. The company first focuses on technological solutions that will revolutionize current practices in Public Health. Aenitis Technologies aims to become a world leader in filtering / separating solutions by acoustophoresis.
Kayentis SAS specializes in electronic clinical outcome assessment (eCOA) and electronic data capture solutions, primarily serving pharmaceutical companies and clinical trial organizations. Founded in 2003 and headquartered in Meylan, France, with additional offices in Boston and Tokyo, the company provides a range of tools designed to streamline clinical trials. Their offerings include Clin'form, a web portal for data management; ePEN, a data capture solution that reduces study duration and costs; and Kayentis Tablet for site-based eClinRO and ePRO data collection. Kayentis also offers project management, design and validation services, training, and comprehensive data management, enhancing the efficiency of clinical trial data collection for sponsors and operators.
Open Ocean is an innovative company based in Brest and Paris, which conceives since 2011 online decision-making solutions for industrial marine activities.
Their highly qualified team of oceanographers, trained in the best research oceanographic institutes of the world (UPMC, IFREMER, University of Washington) is specialized in high resolution modelling, statistical analysis and data mining.
JobTeaser SARL operates a recruitment platform designed for students and recent graduates, facilitating access to internships, job placements, and entry-level positions. Established in 2008 and based in Paris, France, the platform offers over 5,000 job opportunities and provides multimedia resources such as videos showcasing various companies and career paths. Additionally, JobTeaser offers career guidance, advice on job selection, and opportunities for users to engage directly with recruiters. The platform aims to enhance the job search experience for young professionals by combining practical job listings with valuable support and insights into potential career trajectories.
MaaT Pharma, SA, operates as a biotechnology company. It develops therapies to treat diseases related to gut microbiota imbalance. It also develops a series of microbiome-based drugs which targets mortality and comorbidities associated with blood cancer treatment. The company was founded in 2014 and is based in Lyon, France.
MinuteBuzz is a social media entertainment platform that specializes in curating viral stories for a youthful audience aged 18 to 35. Over the past three years, it has established itself as a prominent source of humor and engaging content on social networks. The company employs algorithmically-controlled feeds to enhance user experience and optimize advertisement revenue, positioning itself as a pioneer in native advertising in France. By focusing on the latest trends and popular narratives, MinuteBuzz effectively attracts millions of monthly visitors, contributing significantly to the online advertising market.
Enterome SA is a biotechnology company based in Paris, France, with an additional office in Cambridge, Massachusetts. Founded in 2008, it specializes in disease management solutions that leverage its understanding of the gut microbiome. The company focuses on developing biomarkers, companion diagnostics, and therapeutics aimed at treating various microbiome-related diseases, including inflammatory bowel diseases and metabolic disorders. Enterome's innovative approach involves identifying bioactive molecules differentially expressed by the gut microbiome, which are crucial for regulating human physiology and immune responses. The company has established a strategic collaboration with Takeda Pharmaceutical Company to enhance its research and development efforts. By integrating its expertise in the gut microbiome with therapeutic development, Enterome aims to create targeted solutions for complex health challenges.
Webinterpret S.A.S, founded in 2007 and headquartered in Valbonne, France, specializes in facilitating international e-commerce for sellers by providing comprehensive solutions that enable them to advertise and sell products across various global online marketplaces, including Amazon and eBay. The company offers a range of services such as shipping cost adjustments, currency conversion, accurate translations, and international stock management, which collectively assist online retailers in expanding their reach and increasing sales. With additional offices in the United Kingdom, the United States, and Poland, Webinterpret employs approximately 210 skilled e-commerce specialists who possess in-depth knowledge of local markets, contributing to the company's mission of democratizing access to international e-commerce for all sellers.
PrestaShop SA is a leading provider of open-source e-commerce software, enabling businesses worldwide to establish and manage online stores. Founded in 2007 and headquartered in Paris, France, with an additional office in Miami, the company offers a range of features, including customizable store templates, a user-friendly website builder, and mobile responsiveness. PrestaShop has become one of the most popular e-commerce platforms globally, with over 300,000 online stores utilizing its technology. The company's mission focuses on fostering open-source innovation to help users succeed in the digital marketplace. Through its collaborative approach with the community, PrestaShop continues to enhance its software offerings, earning recognition such as the 2016 CMS Critic Award for Best eCommerce Software and a place on the Inc. 5000 list of fastest-growing private companies in Europe.
Private Equity Round in 2013
EndoControl develops and distributes collaborative robots (cobots) designed to assist surgeons during laparoscopic procedures, enhancing the efficiency and precision of minimally invasive surgeries. Founded in 2006 and based in La Tronche, France, the company offers a range of innovative products, including VIKY EP, a motorized endoscope positioner, VIKY UP, a motorized uterus positioner, and JAIMY, an articulated robotized instrument for 5-mm incisions. These technologies aim to address the challenges associated with laparoscopic surgery, which, while beneficial for patients due to its minimally invasive nature, presents technical difficulties for surgeons. EndoControl's solutions enable surgeons to perform robotic-assisted surgery directly at the operating room table, facilitating improved access and control during procedures. The company operates internationally, working closely with medical professionals to enhance surgical outcomes. As of June 2019, EndoControl operates as a subsidiary of Canady Life Sciences, Inc.
E-Blink specializes in developing innovative solutions for the deployment of mobile network base stations. The company focuses on creating technologies that eliminate the reliance on coaxial cables and short-range fiber optics, with its flagship product, the EB1 system, leading the way. This system enhances deployment flexibility and reduces costs while facilitating better integration of equipment within the base station environment. By offering these advanced solutions, E-Blink positions itself as a leader in fronthaul technologies, catering to the evolving needs of mobile network operators.
Streamdata.io is a software developer focused on API management that specializes in real-time data streaming through its event-driven infrastructure. Founded in 2008 and headquartered in Meylan, France, the company offers three primary services: Distribute, Journey, and Discover. Distribute enables organizations to transform traditional request/response models into streams of events, while Journey provides consulting and tools to assist businesses in managing their API lifecycle. Discover helps companies catalog their digital assets to create effective APIs. Streamdata.io has collaborated with notable partners, including Xignite and Salesforce, to enhance its offerings in financial markets. The company has received several accolades, including the European Data Award at Vivatech and recognition as one of the top AI startups in France. As a subsidiary of Axway Software, Streamdata.io also contributes to industry standards like AsynchAPI and OpenAPI. The company maintains a presence both in France and the United States.
Global Bioenergies SA is a French company established in 2008, specializing in the development of a biological process to convert renewable resources into isobutene, a crucial petrochemical building block. The company is unique in Europe for its innovative approach to producing hydrocarbons through fermentation, focusing not only on isobutene but also on other gaseous olefins such as propylene and butadiene. In addition to its production efforts, Global Bioenergies offers engineering services related to gas fermentation processes and is engaged in converting industrial emissions and gaseous carbon sources into valuable chemical compounds. The company operates an industrial pilot and is constructing a demonstration plant in Germany, while preparing for its first full-scale facility through a joint venture with Cristal Union called IBN-One.
Private Equity Round in 2013
Advanced Accelerator Applications (AAA), is a European Pharmaceutical Group founded in 2002 by Italian academics as a spin-off of the “European Organization for Nuclear Research” (CERN), Geneva, Switzerland), to develop innovative diagnostic and therapeutic products.
AAA’s main focus is in the field of Molecular Imaging and targeted, individualized therapy for the management of patients with serious conditions (Personalized Medicine).
AAA is a European leader in the production and commercialization of PET (Positron Emission Tomography) radiopharmaceuticals. PET is a state-of-the-art diagnostic technique that is today mainly used in clinical oncology, cardiology and neurology. AAA also produces a broad range of SPECT products.
AAA currently has 17 production and R&D facilities able to manufacture both diagnostics and therapeutic MNM products, and has over 300 employees in 11 countries (France, Italy, UK, Germany, Switzerland, Spain, Poland, Portugal, Israel, United States and Canada).
Nexess SAS develops and sells security management solutions for nuclear and Seveso-type plants. It offers NexLink, a software platform for security and productivity; identification products, such as personal security badges, RFID tags, optical tags, high temperature RFID tags, touch based self service counters, mobile devices, rugged mobile systems, NexLink display screens, and smart cabinets; smart camera systems that offers autonomous image analysis and real time data transmission; and RFID antenna systems, which allows objects detection and surveillance in harsh environments. The company offers its products for applications, such as hazardous products traceability, smart automatic secured cabinets to manage equipments, site localization equipments and operation securing, and hazardous zone access detection. Nexess SAS was founded in 2006 and is based in Mougins, France with an additional office in Paris, France.
Recommerce Group specializes in the trade-in and remarketing of second-hand mobile phones, offering a comprehensive range of solutions for the refurbishment and resale of smartphones. The company employs advanced proprietary technologies to give new life to used devices, facilitating both buyback and resale processes. Its services encompass multi-channel trade-in solutions, including reverse logistics, data erasure, and customer support, as well as graphic design and web development for marketing initiatives. Recommerce Group also provides rental options for smartphones and tablets on flexible terms. Operating internationally, the company collaborates with prominent retailers and mobile network operators in France, Switzerland, and Spain, while maintaining a network of physical and online distribution channels. Founded in 2009 and headquartered in Paris, France, Recommerce Group also has additional offices in Grenoble, Warsaw, Madrid, and Fribourg, positioning itself as a leader in the European recommerce market.
TxCell S.A. is a biotechnology company based in Valbonne, France, specializing in cellular immunotherapies that leverage regulatory T cells (Tregs) to address severe chronic inflammatory diseases, autoimmunity, and transplantation challenges. The company develops innovative therapies using Tregs engineered with chimeric antigen receptors (CARs) for various conditions, including TX200, aimed at preventing graft rejection in solid organ transplants, and treatments for autoimmune diseases such as bullous pemphigoid and multiple sclerosis. TxCell is also advancing Ovasave, a therapy for refractory Crohn's disease, having completed an initial study with positive outcomes and planning further clinical trials. The company collaborates with prominent research institutions, including the Lübeck Institute of Experimental Dermatology and the University of British Columbia, to enhance its research and development efforts. TxCell operates as a subsidiary of Sangamo Therapeutics, Inc., continuing its focus on innovative immunotherapy solutions.
Biophytis is a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases.
Their goal is to become a leader in the emerging field of aging science by delivering life-changing therapies to the growing number of patients in need that have limited or no treatment options.
To accomplish this goal, they have assembled an experienced and skilled group of industry professionals, scientists, clinicians and key opinion leaders from leading industry and academic institutions from around the world.
Web Geo Services SAS, founded in 2009 and headquartered in Montpellier, France, specializes in online mapping and geolocation applications. The company provides location-based software as a service (SaaS) technology tailored for various industries, including retail, e-commerce, travel, hospitality, banking, and automotive. By leveraging Google Maps, Web Geo Services assists businesses in enhancing customer engagement and driving conversions through effective digital systems. The company has established itself as a leading partner of Google Cloud in Europe and has successfully collaborated with more than 400 large companies. Its flagship product, Woosmap, is recognized for enabling developers to integrate advanced location intelligence features into mobile applications and websites. Web Geo Services focuses on delivering innovative solutions that empower clients to optimize online customer journeys and boost revenue.
Domain Therapeutics SA is a biopharmaceutical company based in Illkirch-Graffenstaden, France, focused on the discovery and early development of therapeutic drugs targeting G Protein-Coupled Receptors (GPCRs), which are key drug targets in various diseases. The company specializes in developing treatments for Central Nervous System (CNS) disorders and cancer. Utilizing its proprietary DTect-All technology, Domain Therapeutics identifies both orthosteric and allosteric ligands, including Silent Allosteric Modulators (SAMs), which are not discoverable through conventional methods. This innovative approach allows the company to address challenging GPCRs, including orphan and peptidic receptors. Founded in 2001, the company was previously known as Faust Pharmaceuticals SA before rebranding in December 2008.
ProTip SA is a privately held medical device company dedicated to the development of innovative solutions for patients suffering from larynx malfunctions. Its priority focus is to develop a permanent implant for laryngectomized patients. ProTip, based in Strasbourg (Eastern France), was founded in 2004 and has since benefited from strong support from the Alsace region and Oseo, the French public agency for innovation. The company has won several prestigious awards in France. It has established partnerships with a number of academic institutions. The international expansion of the company has recently accelerated due to the ISO certification and CE mark achievement on essential product lines.
Netino specializes in monitoring social conversations and ensuring appropriate responses on a round the clock basis.
LNC Therapeutics is developing gut microbiota directed drugs to target obesity and associated cardiometabolic diseases. All projects encompass fundamental research, preclinical studies and clinical trials. Backed by leading venture capital investors, such as Seventure Partners (with the microbiome dedicated vehicle Health for Life Capital) and Family Offices, the company cultivates worldwide collaborations with renowned medical experts to ensure the highest level of standards in the development of innovative drugs. With a total of € 16.5 million raised so far including € 1.5 million grants from French BPI and Aquitaine Region, LNC Therapeutics will pursue its research programs to bring the next generation approach to treat obesity and cardiometabolic diseases.
E-Blink specializes in developing innovative solutions for the deployment of mobile network base stations. The company focuses on creating technologies that eliminate the reliance on coaxial cables and short-range fiber optics, with its flagship product, the EB1 system, leading the way. This system enhances deployment flexibility and reduces costs while facilitating better integration of equipment within the base station environment. By offering these advanced solutions, E-Blink positions itself as a leader in fronthaul technologies, catering to the evolving needs of mobile network operators.
Enterome SA is a biotechnology company based in Paris, France, with an additional office in Cambridge, Massachusetts. Founded in 2008, it specializes in disease management solutions that leverage its understanding of the gut microbiome. The company focuses on developing biomarkers, companion diagnostics, and therapeutics aimed at treating various microbiome-related diseases, including inflammatory bowel diseases and metabolic disorders. Enterome's innovative approach involves identifying bioactive molecules differentially expressed by the gut microbiome, which are crucial for regulating human physiology and immune responses. The company has established a strategic collaboration with Takeda Pharmaceutical Company to enhance its research and development efforts. By integrating its expertise in the gut microbiome with therapeutic development, Enterome aims to create targeted solutions for complex health challenges.
Streamdata.io is a software developer focused on API management that specializes in real-time data streaming through its event-driven infrastructure. Founded in 2008 and headquartered in Meylan, France, the company offers three primary services: Distribute, Journey, and Discover. Distribute enables organizations to transform traditional request/response models into streams of events, while Journey provides consulting and tools to assist businesses in managing their API lifecycle. Discover helps companies catalog their digital assets to create effective APIs. Streamdata.io has collaborated with notable partners, including Xignite and Salesforce, to enhance its offerings in financial markets. The company has received several accolades, including the European Data Award at Vivatech and recognition as one of the top AI startups in France. As a subsidiary of Axway Software, Streamdata.io also contributes to industry standards like AsynchAPI and OpenAPI. The company maintains a presence both in France and the United States.
Tigerlily SAS is a social customer engagement company based in Paris, France, established in 2010. The company provides a platform that enables brands, advertising agencies, and organizations to acquire, engage, and monetize customers on social media. Its offerings include Page Builder, which allows users to customize Facebook tabs to attract fans and direct them to their websites. The platform also features tools for managing conversations and branding across various social media channels, utilizing automated processes to enhance web exposure through social interactions like comments and shares. Additionally, Tigerlily's platform equips brands and marketing consultants with insights into community engagement and customer behavior, facilitating the creation of effective multi-platform digital campaigns across web, mobile, and tablet devices.
Impeto Medical SAS is a privately owned medical device company based in Paris, France, founded in 2005. The company specializes in the manufacture and marketing of non-invasive diagnostic devices that assess eccrine sweat gland activity. Its key products include SUDOSCAN+, which detects and monitors peripheral autonomic neuropathy; EZSCAN, designed for screening and preventing diabetes and metabolic risks; and SUDOSCAN, which evaluates galvanic skin response to analyze sympathetic nervous system behavior in various conditions, such as diabetes and Parkinson's disease. Impeto Medical utilizes patented technology to assess sudomotor function, enabling healthcare providers to screen large patient populations and identify diseases at an early stage. The company distributes its products through a network of distributors and operates subsidiary locations in China and San Diego, California.
TalentSoft SA is a developer of cloud-based talent management software, founded in 2007 and based in Boulogne-Billancourt, France. The company offers a comprehensive suite of solutions that support various aspects of talent management, including employee recruitment, performance appraisal, career development, learning, and compensation management. Its software facilitates multilingual employee portals, enhances employer branding, and allows for the customization of appraisal documents and development plans. Additionally, TalentSoft promotes internal mobility and provides tools for effective workforce and competency planning. The company has established a global presence with subsidiaries and partnerships across Africa, North America, Asia, and Europe, demonstrating its commitment to international growth. TalentSoft’s innovative approach and strategic collaborations with major technology firms, such as Microsoft, have solidified its position as a leader in the SaaS-based talent management sector.
Enterome SA is a biotechnology company based in Paris, France, with an additional office in Cambridge, Massachusetts. Founded in 2008, it specializes in disease management solutions that leverage its understanding of the gut microbiome. The company focuses on developing biomarkers, companion diagnostics, and therapeutics aimed at treating various microbiome-related diseases, including inflammatory bowel diseases and metabolic disorders. Enterome's innovative approach involves identifying bioactive molecules differentially expressed by the gut microbiome, which are crucial for regulating human physiology and immune responses. The company has established a strategic collaboration with Takeda Pharmaceutical Company to enhance its research and development efforts. By integrating its expertise in the gut microbiome with therapeutic development, Enterome aims to create targeted solutions for complex health challenges.